Dr. Yeang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UCSD Rancho Bernado
16950 Via Tazon
San Diego, CA 92127Phone+1 800-926-8273- Is this information wrong?
Clinical Expertise
- Atherosclerosis, Preventive cardiology, Lipid metabolism disorders, Lipoprotein disorders, Lipoprotein(a)
Education & Training
- University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 2014 - 2019
- UC San Diego Medical Center - HillcrestPost-Doctoral Fellowship, Postdoctoral fellow (molecular biology), 2014 - 2019
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2012 - 2014
- State University of New York Downstate Medical Center College of MedicineClass of 2012
Certifications & Licensure
- CA State Medical License 2013 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- High lipoprotein(a): Actionable strategies for risk assessment and mitigation.Gissette Reyes-Soffer, Wess Boatwright, Calvin Yeang, Erin D Michos, Christie M Ballantyne> ;American Journal of Preventive Cardiology. 2024 Jun 1
- Lipoprotein(a) is a Prevalent yet Vastly Underrecognized Risk Factor for Cardiovascular Disease.Jacob Rendler, Mia Murphy, Calvin Yeang> ;Health Care. Current Reviews. 2024 Jan 1
- Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease.Maximillian A Rogers, Francesca Bartoli-Leonard, Kang H Zheng, Aeron M Small, Hao Yu Chen, Cassandra L Clift, Takaharu Asano, Shiori Kuraoka, Mark C Blaser, Katelyn A ...> ;Circulation. 2024 Jan 30
- Join now to see all
Lectures
- Lp(a)-Cholesterol and True LDL-Cholesterol: Implications for Refining CVD Risk Attributed to LDL and Lp(a)Lipoprotein(a) Symposium, EAS endorsed satellite meeting - 5/24/2019
- The Role of Lp(a) in Calcific Aortic Valve Disease: Clinical and Basic Research EvidenceHeart Valve Society - 4/12/2018
Authored Content
- The Role of Lipoprotein(A) in Calcific AV Disease and Insights into Its Medical TherapiesApril 2020
- The Role of Lipoprotein(A) in Calcific AV Disease and Insights into Its Medical TherapiesApril 2020
- PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes with a Human Antibody Detects Clinically Relevant AtherothrombosisJanuary 2018
- PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes with a Human Antibody Detects Clinically Relevant AtherothrombosisJanuary 2018
- Join now to see all
Grant Support
- Defining the Role of Lipoprotein(a) and its Oxidized Phospholipids in the Development and Progression of Calcific Aortic Valve Disease Using Unique Transgenic Mouse ModelsNIH/NHLBI2020–2025
Professional Memberships
- Member
- Member
- European Atherosclerosis SocietyMember
Other Languages
- Chinese (Mandarin)
Hospital Affiliations
- UC San Diego Medical Center - HillcrestSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: